Business Description
JFL Life Sciences Ltd
ISIN : INE0LA901015
Compare
Compare
Traded in other countries / regions
JFLLIFE.India IPO Date
2022-09-08Description
JFL Life Sciences Ltd is engaged in the business of manufacturing pharmaceutical products. The company's product portfolio consists of Dry powder injections (B-Lactam), Tablets and Capsules (B-Lactam) solid oral dosage forms, and general tablets and capsules. Its operating segment comprises of manufacturing and selling of pharmaceutical products. Geographically, the company sells its products both in India and outside India.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.01 | |||||
| Equity-to-Asset | 0.63 | |||||
| Debt-to-Equity | 0.16 | |||||
| Debt-to-EBITDA | 1.14 | |||||
| Interest Coverage | 5.59 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.9 | |||||
| Beneish M-Score | -2.64 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.4 | |||||
| 3-Year EBITDA Growth Rate | 30.4 | |||||
| 3-Year EPS without NRI Growth Rate | 82.9 | |||||
| 3-Year Book Growth Rate | 73 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 32.16 | |||||
| 9-Day RSI | 56.57 | |||||
| 14-Day RSI | 63.89 | |||||
| 6-1 Month Momentum % | 159.34 | |||||
| 12-1 Month Momentum % | 143.86 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.16 | |||||
| Quick Ratio | 1.37 | |||||
| Days Inventory | 134.13 | |||||
| Days Sales Outstanding | 36.56 | |||||
| Days Payable | 80.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.25 | |||||
| Forward Dividend Yield % | 0.25 | |||||
| 5-Year Yield-on-Cost % | 0.25 | |||||
| Shareholder Yield % | 1.62 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 16.52 | |||||
| Operating Margin % | 8.92 | |||||
| Net Margin % | 7.11 | |||||
| FCF Margin % | 4.86 | |||||
| ROE % | 9.75 | |||||
| ROA % | 6.26 | |||||
| ROIC % | 8.21 | |||||
| ROC (Joel Greenblatt) % | 22.2 | |||||
| ROCE % | 12.87 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 32.9 | |||||
| PE Ratio without NRI | 32.9 | |||||
| Price-to-Owner-Earnings | 24.37 | |||||
| PEG Ratio | 0.83 | |||||
| PS Ratio | 2.34 | |||||
| PB Ratio | 3.06 | |||||
| Price-to-Tangible-Book | 3.06 | |||||
| Price-to-Free-Cash-Flow | 48.18 | |||||
| Price-to-Operating-Cash-Flow | 13.03 | |||||
| EV-to-EBIT | 25.21 | |||||
| EV-to-EBITDA | 22.97 | |||||
| EV-to-Revenue | 2.46 | |||||
| EV-to-FCF | 50.65 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.32 | |||||
| Price-to-Graham-Number | 2.12 | |||||
| Price-to-Net-Current-Asset-Value | 4.93 | |||||
| Earnings Yield (Greenblatt) % | 3.97 | |||||
| FCF Yield % | 2.08 | |||||
| Forward Rate of Return (Yacktman) % | 17.22 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JFL Life Sciences Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 465.479 | ||
| EPS (TTM) (₹) | 1.003 | ||
| Beta | 0 | ||
| Volatility % | 82.82 | ||
| 14-Day RSI | 63.89 | ||
| 14-Day ATR (₹) | 0.329152 | ||
| 20-Day SMA (₹) | 33.46 | ||
| 12-1 Month Momentum % | 143.86 | ||
| 52-Week Range (₹) | 12.016666 - 37.15 | ||
| Shares Outstanding (Mil) | 33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JFL Life Sciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JFL Life Sciences Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
JFL Life Sciences Ltd Frequently Asked Questions
What is JFL Life Sciences Ltd(NSE:JFLLIFE)'s stock price today?
The current price of NSE:JFLLIFE is ₹33.00. The 52 week high of NSE:JFLLIFE is ₹37.15 and 52 week low is ₹12.02.
When is next earnings date of JFL Life Sciences Ltd(NSE:JFLLIFE)?
The next earnings date of JFL Life Sciences Ltd(NSE:JFLLIFE) is .
Does JFL Life Sciences Ltd(NSE:JFLLIFE) pay dividends? If so, how much?
The Dividend Yield %  of JFL Life Sciences Ltd(NSE:JFLLIFE) is 0.25% (As of Today), Highest Dividend Payout Ratio of JFL Life Sciences Ltd(NSE:JFLLIFE) was 0. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of JFL Life Sciences Ltd(NSE:JFLLIFE) is 0.25%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers